SCHEMBL21786996

SCHEMBL21786996

CC(C)CCCCCC(=O)NCC(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.51
EPHX2 P34913 4/20 0.47
KDM4C Q9H3R0 2/20 0.46
KDM4A O75164 1/20 0.46
PHF8 Q9UPP1 1/20 0.46
KDM2A Q9Y2K7 1/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
DEGS1 O15121 1/20 0.44
FAAH O00519 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26445194 1.00 HPGD (0.51) HPGDEPHX2KDM4CKDM4APHF8
SCHEMBL23613251 1.00 HPGD (0.51) HPGDEPHX2KDM4CKDM4APHF8
SCHEMBL26445193 1.00 HPGD (0.51) HPGDEPHX2KDM4CKDM4APHF8
Hydrochloric Acid SCHEMBL7280267 0.98 HPGD (0.50) HPGDEPHX2KDM4CKDM4APHF8
SCHEMBL21786998 0.98 HPGD (0.53) HPGDEPHX2KDM4CKDM4APHF8
SCHEMBL16625022 0.92 HPGD (0.54) HPGDEPHX2CYP2D6CYP2C19CYP1A2
SCHEMBL874764 0.89 ALDH1A1 (0.46) HPGDEPHX2KDM4CKDM4APHF8
SCHEMBL24297139 0.86 HPGD (0.44) HPGDEPHX2KDM4CKDM4APHF8
SCHEMBL425951 0.86 ALDH1A1 (0.55) HPGDKDM4CKDM4APHF8KDM2A
SCHEMBL2540536 0.86 KDM4C (0.47) HPGDKDM4CKDM4APHF8KDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024107763-A1 N6-ADENOSINE-METHYLTRANSFERASE PROTACS AND METHODS OF USE THEREOF UNIVERSITY OF ZURICH (CH) 2024-05-23 WO disclosed
US-20230295437-A1 SILICON CONTAINING DETECTABLE COMPOUNDS Singular Genomics Systems, Inc. 2023-09-21 US disclosed
US-20230227798-A1 MODIFIED THERMOCCOCUS POLYMERASES FIRST-CITIZENS BANK & TRUST COMPANY 2023-07-20 US disclosed
US-11697736-B2 Silicon containing detectable compounds Singular Genomics Systems, Inc. (US) 2023-07-11 US disclosed
US-11697736-B2 Silicon containing detectable compounds Singular Genomics Systems, Inc. (US) 2023-07-11 US disclosed
US-20230028321-A1 NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-01-26 US disclosed
US-11034942-B1 Modified pyrococcus polymerases and uses thereof Singular Genomics Systems, Inc. (US) 2021-06-15 US disclosed
CN-110669947-B Extraction system for separating calcium from calcium-containing brine by using secondary amide/alkyl alcohol composite solvent to extract lithium and boron, extraction method and application thereof 湘潭大学 2021-05-25 CN disclosed
CN-110643834-B Extraction system for separating calcium from calcium-containing brine by using secondary amide/alkyl ester composite solvent to extract lithium, extraction method and application thereof 湘潭大学 2021-05-25 CN disclosed
CN-110777267-B Extraction system for separating calcium from calcium-containing brine by using secondary amide/tertiary amide composite solvent to extract lithium, extraction method and application thereof 湘潭大学 2021-05-25 CN disclosed
US-20200069717-A1 NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-03-05 US disclosed
CN-110777266-A Extraction system for separating calcium from calcium-containing brine by using secondary amide/alkane composite solvent to extract lithium, extraction method and application thereof 湘潭大学 2020-02-11 CN disclosed
CN-110777267-A Extraction system for separating calcium from calcium-containing brine by using secondary amide/tertiary amide composite solvent to extract lithium, extraction method and application thereof 湘潭大学 2020-02-11 CN disclosed
CN-110669947-A Extraction system for separating calcium from calcium-containing brine by using secondary amide/alkyl alcohol composite solvent to extract lithium and boron, extraction method and application thereof 湘潭大学 2020-01-10 CN disclosed
CN-110656249-A Extraction system for separating magnesium from magnesium-containing brine by using secondary amide/alkane composite solvent, extraction method and application thereof 湘潭大学 2020-01-07 CN disclosed
CN-110656248-A Extraction system for separating magnesium from magnesium-containing brine by using secondary amide/alkyl alcohol composite solvent to extract lithium and boron, extraction method and application thereof 湘潭大学 2020-01-07 CN disclosed
CN-110643813-A Extraction system for separating calcium from calcium-containing brine by using secondary amide/alkyl ketone composite solvent to extract lithium, extraction method and application thereof 湘潭大学 2020-01-03 CN disclosed
CN-110643834-A Extraction system for separating calcium from calcium-containing brine by using secondary amide/alkyl ester composite solvent to extract lithium, extraction method and application thereof 湘潭大学 2020-01-03 CN disclosed
CN-110643835-A Extraction system, extraction method and application for separating magnesium from magnesium-containing brine by using secondary amide solvent to extract lithium 湘潭大学 2020-01-03 CN disclosed
CN-110643833-A Extraction system for separating magnesium from magnesium-containing brine by using secondary amide/tertiary amide composite solvent and extracting lithium, extraction method and application thereof 湘潭大学 2020-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11697736-B2 Silicon containing detectable compounds AS3MT, SCLY, NASP HPGD 3941/4885EPHX2 3334/4885KDM4C 2261/4885
US-20200069717-A1 NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF POLRMT, NSUN2, RNGTT HPGD 1454/4885EPHX2 2325/4885KDM4C 3188/4885
US-20230295437-A1 SILICON CONTAINING DETECTABLE COMPOUNDS AS3MT, SCLY, NASP HPGD 3941/4885EPHX2 3334/4885KDM4C 2261/4885
US-20230028321-A1 NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF POLRMT, NSUN2, NUDT1 HPGD 1426/4885EPHX2 2217/4885KDM4C 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.